ArticleBMC complementary medicine and therapies2025
Prevalence and factors associated with the use of complementary and alternative medicine among PCOS patients.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications.Frontiers in reproductive health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic Ovarian Syndrome (PCOS) is the most common endocrinopathy in women and the most common cause of anovulatory infertility. It is considered incurable in conventional medicine and both patients and physicians have expressed dissatisfaction with delayed diagnosis, challenging and unsatisfactory management regimen used. Global interest in Complementary and alternative medicine (CAM) is rising, and patients have expressed a desire to find a safe and effective treatment for their PCOS.
objectiveThe objective of this study was to determine the prevalence and factors associated with the use of complementary and alternative medicine among PCOS patients. METHODOLOGY: A sample size of 209 was calculated; however, due to a response rate of 86%, a total of 180 questionnaires were analyzed. The study employed a universal sampling method. An analytic cross-sectional study was conducted on 180 patients with PCOS recruited from 2 hospitals. Validated self-administered questionnaire was used and data was analyzed using SPSS version 25.0. Independent variables included socio-demographic factors, perceived severity, benefits, and barriers. Binary logistic regression was used to analyze the relationship between CAM use and perceived severity, benefit, barriers, and health locus of control, while the chi-square test examined the link between socio-demographic factors and CAM use.
resultsA total of 180 patients with PCOS responded to the study. 67.2% of respondents were aged 30-39, with infertility being the most common symptom (85.2%). The prevalence of CAM use was 57.8%, and 12.8% of respondents reported side effects. Ethnicity (Malay) was significantly associated with CAM use (x² = 4.408, p = 0.036), and perceived benefit also showed a significant association (OR = 2.09, p = 0.007). However, perceived severity, perceived barrier, and health locus of control had no significant association with CAM use.
conclusionIn conclusion, this study established the prevalence of complementary and alternative medicine (CAM) use among patients with polycystic ovary syndrome (PCOS) and highlighted key factors influencing their preference for such treatments. These findings provide valuable insights for healthcare providers and policymakers to better understand patient behavior and treatment choices, ultimately aiding in the development of more patient-centered, culturally sensitive, and effective management strategies for PCOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.